ORIC: ORIC Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ORIC: ORIC Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 516.77
Enterprise Value ($M) 493.39
Book Value ($M) 224.09
Book Value / Share 3.33
Price / Book 2.31
NCAV ($M) 184.68
NCAV / Share 2.74
Price / NCAV 2.80

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 10.39
Current Ratio 10.39

Balance Sheet (mrq) ($M)
Current Assets 212.60
Assets 252.01
Liabilities 27.92
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -110.78
Net Income -100.70

Cash Flow Statement (mra) ($M)
Cash From Operations -85.69
Cash from Investing -43.40
Cash from Financing 85.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-11 13G/A Fmr Llc 7.56 -27.24
02-14 13G/A EcoR1 Capital, LLC 8.90 83.59
02-13 13G/A Prosight Management, LP 2.90 -30.80
02-13 13G/A Alkeon Capital Management Llc 6.60 50.22
02-07 13G/A BlackRock Inc. 4.50 -3.25
02-06 13G/A Millennium Management Llc 0.00 -100.00
02-01 13G Venrock Healthcare Capital Partners III, L.P. 6.60
01-30 13G Viking Global Investors Lp 5.90
01-25 13G Frazier Life Sciences Public Fund, L.P. 6.20
07-07 13G Nextech Crossover I GP S.a r.l. 7.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 45,314 170,245 26.62
2024-04-25 86,561 282,495 30.64
2024-04-24 63,073 163,377 38.61

(click for more detail)

Similar Companies
OMGA – Omega Therapeutics, Inc. OPK – OPKO Health, Inc.
OPTN – OptiNose, Inc. OVID – Ovid Therapeutics Inc.
PASG – Passage Bio, Inc.


Financial data and stock pages provided by
Fintel.io